This story was updated following CVS Health's earnings call Wednesday morning. | The company reported improvements in its ...

Gilead Sciences said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including $39 million for ...

That said, CVS continues to maintain a prudent outlook for possible changes in the vaccine market demand and a softening ...

Q3 2025 Earnings Call Transcript October 29, 2025 CVS Health Corporation beats earnings expectations. Reported EPS is $1.6, ...

Farmington-based UConn Health is warning thousands of patients with Aetna insurance coverage that they may lose their ...

Reflecting the ‘Better Always’ philosophy – symbolising a leap towards cleaner, and intelligent solutions, its Euro 6 ...

Rich Pavek retires after nearly 45 years with Cedar Valley Services, passing leadership to Garry Hart, who aims to continue ...

The leading candidates for St. Paul mayor — incumbent Melvin Carter and state Rep. Kaohly Her — have broadly similar goals for the city, with both campaigns leaning into messages of economic ...

Cigna will eliminate prescription drug rebates in many of its commercial health plans in 2027, upending a practice that’s ...

Explore Gilead Sciences' Q3 2025 earnings: strong HIV portfolio growth, Yeztugo's rapid launch, and raised guidance.

Matt Swain has become a pioneer by pairing family offices looking to triple their money with under-the-radar businesses looking to exit.

Iowa’s law putting new regulations on pharmacy benefits managers is temporarily blocked from enforcement for Wellmark Blue ...